Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Dec 04, 2024 11:08 HKT/SGT Read More
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Dec 02, 2024 10:34 HKT/SGT Read More
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate Nov 30, 2024 21:08 HKT/SGT Read More
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC Nov 30, 2024 20:34 HKT/SGT Read More
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea Nov 28, 2024 15:26 HKT/SGT Read More
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan Nov 26, 2024 14:50 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 14:30 HKT/SGT Read More
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Nov 15, 2024 13:31 HKT/SGT Read More
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Nov 08, 2024 09:31 HKT/SGT Read More
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting Nov 07, 2024 10:40 HKT/SGT Read More